ATRX and sarcoma: Sarcomas, which are cancers of connective tissues, have recurrent loss of ATRX in up to 30% of specific subtypes, suggesting the potential importance of ATRX deficiency in sarcoma biology and possibilities for precision medicine approaches to treatment (8).